{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:50:50Z","timestamp":1785336650341,"version":"3.55.0"},"reference-count":101,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) play a vital role in the pathogenesis of multiple myeloma (MM), especially for tumor invasion and osteolytic osteopathy. By breaking down extracellular matrix (ECM) components and releasing the proteins composing the ECM and growth factors, as well as their receptors, MMPs affect tissue integrity and promote cancer cell invasion and metastasis. A vital pathophysiological characteristic of MM is the progress of osteolytic lesions, which are brought on by interactions between myeloma cells and the bone marrow microenvironment. MMPs, certainly, are one of the fundamental causes of myeloma bone disease due to their ability to degrade various types of collagens. TIMPs, as important regulators of MMP hydrolysis or activation, also participate in the occurrence and evolution of MM and the formation of bone disease. This review focuses on the role of MMP-1, MMP-2, MMP-7, MMP-9, MMP-13, MMP-14, and MMP-15 and the four types of TIMPs in the invasion of myeloma cells, angiogenesis, osteolytic osteopathy, to offer some novel perspectives on the clinical diagnostics and therapeutics of MM.<\/jats:p>","DOI":"10.3389\/fonc.2023.1127407","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T08:53:23Z","timestamp":1695804803000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Matrix metalloproteinases and tissue inhibitors in multiple myeloma: promote or inhibit?"],"prefix":"10.3389","volume":"13","author":[{"given":"Yan-Ying","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu-Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Hui","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)00135-5","article-title":"Multiple myeloma","volume":"397","author":"van de Donk","year":"2021","journal-title":"Lancet (London England)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41375-019-0660-0","article-title":"Extramedullary multiple myeloma","volume":"34","author":"Bhutani","year":"2020","journal-title":"Leukemia"},{"key":"B3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1182\/blood-2012-01-379024","article-title":"Myeloma as a model for the process of metastasis: implications for therapy","volume":"120","author":"Ghobrial","year":"2012","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1124\/pharmrev.121.000349","article-title":"Matrix metalloproteinases: from molecular mechanisms to physiology, pathophysiology, and pharmacology","volume":"74","author":"de Almeida","year":"2022","journal-title":"Pharmacol Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"113983","DOI":"10.1016\/j.biopha.2022.113983","article-title":"Cd147 and mmps as key factors in physiological and pathological processes","volume":"157","author":"Asgari","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2005.12.002","article-title":"Structure and function of matrix metalloproteinases and timps","volume":"69","author":"agase","year":"2006","journal-title":"Cardiovasc Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.bbamcr.2009.08.006","article-title":"To bind zinc or not to bind zinc: an examination of innovative approaches to improved metalloproteinase inhibition","volume":"1803","author":"Jacobsen","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"B8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1152\/physiol.00029.2013","article-title":"Matrix metalloproteinase-9: many shades of function in cardiovascular disease","volume":"28","author":"Yabluchanskiy","year":"2013","journal-title":"Physiol (Bethesda Md)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M117.806075","article-title":"Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (Mmp-9) that allosterically inhibits zymogen activation","volume":"292","author":"Scannevin","year":"2017","journal-title":"J Biol Chem"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1996.1688","article-title":"Identification of mmp-18, a putative novel human matrix metalloprotein ase","volume":"228","author":"Cossins","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000070112.80711.3D","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry","volume":"92","author":"Visse","year":"2003","journal-title":"Circ Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bbamcr.2009.07.004","article-title":"Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models","volume":"1803","author":"Fanjul-Fernandez","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"B13","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-818168-3.00010-3","article-title":"Chapter 10 - collagenases and gelatinases and their inhibitors as anticancer agents","volume-title":"Cancer-leading proteases","author":"Adhikari","year":"2020"},{"key":"B14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10555-008-9129-8","article-title":"Mt4-(Mmp17) and mt6-mmp (Mmp25), a unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer","volume":"27","author":"Sohail","year":"2008","journal-title":"Cancer metastasis Rev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nri3499","article-title":"Metalloproteinases and their natural inhibitors in inflammation and immunity","volume":"13","author":"Khokha","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/bs.pmbts.2017.01.001","article-title":"The balance between metalloproteinases and timps: critical regulator O F microvascular endothelial cell function in health and disease","volume":"147","author":"Masciantonio","year":"2017","journal-title":"Prog Mol Biol Transl Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/s0167-4838(99)00279-4","article-title":"Tissue inhibitors of metalloproteinases: evolution, structure and func tion","volume":"1477","author":"Brew","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"B18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbamcr.2010.01.003","article-title":"The tissue inhibitors of metalloproteinases (Timps): an ancient family with structural and functional diversity","volume":"1803","author":"Brew","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/mnm.S156245","article-title":"The role of tissue inhibitors of metalloproteinases in microvascular endothelial cell barrier dysfunction during sepsis","volume":"6","author":"Jayawardena","year":"2019","journal-title":"Metalloproteinases In Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2015.03.005","article-title":"The role of timps in regulation of extracellular matrix proteolysis","author":"Arpino","year":"2015","journal-title":"Matrix Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11030321","article-title":"Bone marrow cx3cl1\/fractalkine is a new player of the pro-angiogenic microenvironment in multiple myeloma patients","volume":"11","author":"Marchica","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.exphem.2011.02.002","article-title":"Gene expression profile of adams and adamtss metalloproteinases in normal and Malignant plasma cells and in the bone marrow environment","volume":"39","author":"Bret","year":"2011","journal-title":"Exp Hematol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-09-3830","article-title":"Adam-9 (Mdc-9\/meltrin-gamma), a member of the a disintegrin and metalloproteinase family, regulates myeloma-cell-induced interleukin-6 production in osteoblasts by direct interaction with the alpha(V)Beta5 integrin","volume":"107","author":"Karadag","year":"2006","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-00329-7","article-title":"The matrix in cancer","volume":"21","author":"Cox","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112260","article-title":"Matrix metalloproteinase-9 (Mmp-9) and its inhibitors in cancer: A minireview","volume":"194","author":"Mondal","year":"2020","journal-title":"Eur J Med Chem"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2004.12.018","article-title":"Par1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells","volume":"120","author":"Boire","year":"2005","journal-title":"Cell"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2008.04.001","article-title":"Matrix metalloproteinases-1 and -2, and tissue inhibitor of metalloproteinase-2 production is abnormal in bone marrow stromal cells of multiple myeloma patients","volume":"32","author":"Zdzisi\u0144ska","year":"2008","journal-title":"Leukemia Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06665.x","article-title":"Osteoblasts promote migration and invasion of myeloma cells through upregulation of matrix metalloproteinases, urokinase plasminogen activator, hepatocyte growth factor and activation of P38 mapk","volume":"138","author":"Hecht","year":"2007","journal-title":"Br J haematol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2013.11.019","article-title":"P38 and jnk mapk pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents","volume":"344","author":"Sui","year":"2014","journal-title":"Cancer Lett"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6096391","article-title":"Dihydroartemisinin modulates apoptosis and autophagy in multiple myeloma through the P38\/mapk and wnt\/beta-catenin signaling pathways","volume":"2020","author":"Wu","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/s1357-2725(01)00007-3","article-title":"Human endothelial gelatinases and angiogenesis","volume":"33","author":"Nguyen","year":"2001","journal-title":"Int J Biochem Cell Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.phrs.2017.05.002","article-title":"Is dual inhibition of metalloenzymes hdac-8 and mmp-2 a potential pharmacological target to combat hematological Malignancies","volume":"122","author":"Amin","year":"2017","journal-title":"Pharmacol Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.734485","article-title":"The imbalance of mmp-2\/timp-2 and mmp-9\/timp-1 contributes to collagen deposition disorder in diabetic non-injured skin","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2020.109332","article-title":"Renoprotective effects of tropisetron through regulation of the tgf-beta1, P53 and matrix metalloproteinases in streptozotocin-induced diabetic rats","volume":"335","author":"Pourheydar","year":"2021","journal-title":"Chem Biol Interact"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-012-0589-7","article-title":"Overexpression of amyloid precursor protein in acute myeloid leukemia enhances extramedullary infiltration by mmp-2","volume":"34","author":"Jiang","year":"2013","journal-title":"Tumor Biol"},{"key":"B36","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V93.9.3064.409k07_3064_3073","article-title":"Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma","volume":"93","author":"Vacca","year":"1999","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1046\/j.1365-2141.2001.03160.x","article-title":"Matrix metalloproteinase and tissue inhibitors of metalloproteinase secretion by haematopoietic and stromal precursors and their production in normal and leukaemic long-term marrow cultures","volume":"115","author":"Marquez-Curtis","year":"2001","journal-title":"Br J haematol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10642","article-title":"Upregulation of matrix metalloproteinase-9 in murine 5t33 multiple myeloma cells by interaction with bone marrow endothelial cells","volume":"101","author":"Van Valckenborgh","year":"2002","journal-title":"Int J Cancer"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi235","article-title":"Myeloma bone disease: pathophysiology and management","volume":"16","author":"Terpos","year":"2005","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3109\/10409238.2013.770819","article-title":"Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (Mmp-9): the next decade","volume":"48","author":"Vandooren","year":"2013","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/biof.1870","article-title":"Altered type I collagen networking in osteoporotic human femoral head revealed by histomorphometric and fourier transform infrared imaging correlated analyses","volume":"48","author":"Licini","year":"2022","journal-title":"BioFactors (Oxford England)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1515\/cclm.2005.160","article-title":"Systemic levels of interleukin-6 and matrix metalloproteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone disease","volume":"43","author":"Sfiridaki","year":"2005","journal-title":"Clin Chem Lab Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2000","journal-title":"J Clin Oncol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/pin.13033","article-title":"Stromal metalloproteinases: crucial contributors to the tumor microenvironment","volume":"71","author":"Shimoda","year":"2021","journal-title":"Pathol Int"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.3390\/cancers13061441","article-title":"Key matrix remodeling enzymes: functions and targeting in cancer","volume":"13","author":"Piperigkou","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.51","article-title":"Microenvironmental regulation of tumour angiogenesis","volume":"17","author":"De Palma","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01271-9","article-title":"Junb is a key regulator of multiple myeloma bone marrow angiogenesis","volume":"35","author":"Fan","year":"2021","journal-title":"Leukemia"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2006.02.017","article-title":"Angiogenesis in multiple myeloma","volume":"42","author":"Jakob","year":"2006","journal-title":"Eur J Cancer"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2020.12.016","article-title":"Thrombopoietin promotes angiogenesis and disease progression in patients with multiple myeloma","volume":"191","author":"Lamanuzzi","year":"2021","journal-title":"Am J Pathol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3109\/14756366.2016.1161620","article-title":"Matrix metalloproteinases (Mmps), the main extracellular matrix (Ecm) enzymes in collagen degradation, as a target for anticancer drugs","volume":"31","author":"Jab\u0142o\u0144ska-Trypu\u0107","year":"2016","journal-title":"J Enzyme Inhib Med Chem"},{"key":"B51","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12943-022-01569-x","article-title":"Targeting tgf-B Signal transduction for fibrosis and cancer therapy","volume":"21","author":"Peng","year":"2022","journal-title":"Mol Cancer"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2004.07.010","article-title":"Regulation of matrix biology by matrix metalloproteinases","volume":"16","author":"Mott","year":"2004","journal-title":"Curr Opin Cell Biol"},{"key":"B53","doi-asserted-by":"crossref","DOI":"10.1101\/gad.14.2.163","article-title":"Cell surface-localized matrix metalloproteinase-9 proteolytically acti vates tgf-beta and promotes tumor invasion and angiogenesis","volume":"14","author":"Yu","year":"2000","journal-title":"Genes Dev"},{"key":"B54","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1083\/jcb.200109100","article-title":"The integrin alpha(V)Beta8 mediates epithelial homeostasis through mt1 -mmp-dependent activation of tgf-beta1","volume":"157","author":"Mu","year":"2002","journal-title":"J Cell Biol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111663200","article-title":"Proteolysis of latent transforming growth factor-beta (Tgf-beta )-bind ing protein-1 by osteoclasts. A cellular mechanism for release of tgf- beta from bone matrix","volume":"277","author":"Dallas","year":"2002","journal-title":"J Biol Chem"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/35036374","article-title":"Matrix metalloproteinase-9 triggers the angiogenic switch during carci nogenesis","volume":"2","author":"Bergers","year":"2000","journal-title":"Nat Cell Biol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-08-3949","article-title":"Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis","volume":"69","author":"Thiolloy","year":"2009","journal-title":"Cancer Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.04.013","article-title":"Mmp-7 promotes prostate cancer-induced osteolysis via the solubilization of rankl","volume":"7","author":"Lynch","year":"2005","journal-title":"Cancer Cell"},{"key":"B60","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.163.10.5723","article-title":"Production of metalloproteinase-7 (Matrilysin) by human myeloma cells and its potential involvement in metalloproteinase-2 activation","volume":"163","author":"Barill\u00e9","year":"1999","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B61","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12943-017-0616-9","article-title":"A loss of host-derived mmp-7 promotes myeloma growth and osteolytic bone disease in vivo","volume":"16","author":"Lwin","year":"2017","journal-title":"Mol Cancer"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-2705","article-title":"Host-derived matrix metalloproteinase-13 activity promotes multiple myeloma-induced osteolysis and reduces overall survival","volume":"81","author":"Lo","year":"2021","journal-title":"Cancer Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1172\/JCI80276","article-title":"Multiple myeloma-derived mmp-13 mediates osteoclast fusogenesis and osteolytic disease","volume":"126","author":"Fu","year":"2016","journal-title":"J Clin Invest"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1646","article-title":"Matrix metalloproteinase-13 is required for osteocytic perilacunar remodeling and maintains bone fracture resistance","volume":"27","author":"Tang","year":"2012","journal-title":"J Bone mineral Res Off J Am Soc Bone Mineral Res"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001150","article-title":"Role of matrix metalloproteinase 13 in both endochondral and intramembranous ossification during skeletal regeneration","volume":"2","author":"Behonick","year":"2007","journal-title":"PloS One"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b00514","article-title":"Structure-based design and synthesis of potent and selective matrix metalloproteinase 13 inhibitors","volume":"60","author":"Choi","year":"2017","journal-title":"J Med Chem"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2010.01.105","article-title":"The role of mt2-mmp in cancer progression","volume":"393","author":"Ito","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1002\/path.1876","article-title":"Role of metalloproteinases mmp-9 and mt1-mmp in cxcl12-promoted myeloma cell invasion across basement membranes","volume":"208","author":"Parmo-Cabanas","year":"2006","journal-title":"J Pathol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2019.1670736","article-title":"Designing New Generation of Potent Inhibitors against Membrane-Type Matrix Metalloproteinase-2: A Computational Effort against Multiple Myeloma","volume":"38","author":"Fakhari","year":"2020","journal-title":"J Biomol Struct Dyn"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2022.110248","article-title":"Mt2-mmp is differentially expressed in multiple myeloma cells and mediates their growth and progression","volume":"92","author":"Fakhari","year":"2022","journal-title":"Cell Signal"},{"key":"B71","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1101\/gad.178749.111","article-title":"Mt1-mmp regulates the pi3kdelta.Mi-2\/nurd-dependent control of macrophage immune function","volume":"26","author":"Shimizu-Hirota","year":"2012","journal-title":"Genes Dev"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M709327200","article-title":"The second dimer interface of mt1-mmp, the transmembrane domain, is essential for prommp-2 activation on the cell surface","volume":"283","author":"Itoh","year":"2008","journal-title":"J Biol Chem"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3390\/ph12020077","article-title":"The expanding role of mt1-mmp in cancer progression","volume":"12","author":"Knapinska","year":"2019","journal-title":"Pharm (Basel)"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/370061a0","article-title":"A matrix metalloproteinase expressed on the surface of invasive tumour cells","volume":"370","author":"Sato","year":"1994","journal-title":"Nature"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M603331200","article-title":"Timp independence of matrix metalloproteinase (Mmp)-2 activation by membrane type 2 (Mt2)-mmp is determined by contributions of both the mt2-mmp catalytic and hemopexin C domains","volume":"281","author":"Morrison","year":"2006","journal-title":"J Biol Chem"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12625767","article-title":"Regulation of vertebrate collagenase activity in vivo and in vitro","volume":"59","author":"Bauer","year":"1972","journal-title":"J Invest Dermatol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/s0014-5793(99)00323-3","article-title":"Reprogramming of timp-1 and timp-3 expression profiles in brain microv ascular endothelial cells and astrocytes in response to proinflammator Y cytokines","volume":"448","author":"Bugno","year":"1999","journal-title":"FEBS Lett"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2004.08.002","article-title":"Timp-1 inhibits microvascular endothelial cell migration by mmp-depend ent and mmp-independent mechanisms","volume":"301","author":"Akahane","year":"2004","journal-title":"Exp Cell Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2008.070891","article-title":"Tissue inhibitor of metalloproteinase-1 moderates airway re-epithelial ization by regulating matrilysin activity","volume":"172","author":"Chen","year":"2008","journal-title":"Am J Pathol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006565","article-title":"Mmp7 shedding of syndecan-1 facilitates re-epithelialization by affect ing alpha(2)Beta(1) integrin activation","volume":"4","author":"Chen","year":"2009","journal-title":"PloS One"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1110\/ps.072978507","article-title":"Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors","volume":"16","author":"Hamze","year":"2007","journal-title":"Protein Sci"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.10.093","article-title":"Myeloma cells self-promote migration by regulating tab1-driven timp-1 expression in mesenchymal stem cells","volume":"534","author":"Rethnam","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3390\/s18103249","article-title":"Matrix metalloproteinase-9 (Mmp-9) as a cancer biomarker and mmp-9 biosensors: recent advances","volume":"18","author":"Huang","year":"2018","journal-title":"Sensors (Basel Switzerland)"},{"key":"B84","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(18)77438-3","article-title":"Tissue inhibitor of metalloproteinases-2 (Timp-2) mrna expression in tumor cell lines and human tumor tissues","volume":"265","author":"Stetler-Stevenson","year":"1990","journal-title":"J Biol Chem"},{"key":"B85","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(19)67878-6","article-title":"Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor mi\/timp-2","volume":"266","author":"DeClerck","year":"1991","journal-title":"J Biol Chem"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M306736200","article-title":"Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration","volume":"278","author":"Endo","year":"2003","journal-title":"J Biol Chem"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1080\/19336918.2019.1639303","article-title":"Timp-2 inhibits metastasis and predicts prognosis of colorectal cancer via regulating mmp-9","volume":"13","author":"Wang","year":"2019","journal-title":"Cell Adhes Migr"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124230","article-title":"Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: A systematic review and meta-analysis","volume":"10","author":"Zhu","year":"2015","journal-title":"PloS One"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.862524","article-title":"Exosomal mir-483-5p in bone marrow mesenchymal stem cells promotes Malignant progression of multiple myeloma by targeting timp2","volume":"10","author":"Gu","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B90","article-title":"Structure and expression in breast tumors of human timp-3, a new member of the metalloproteinase inhibitor family","volume":"54","author":"Ur\u00eda","year":"1994","journal-title":"Cancer Res"},{"key":"B91","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1006\/geno.1994.1016","article-title":"Cloning of the cdna encoding human tissue inhibitor of metalloproteinases-3 (Timp-3) and mapping of the timp3 gene to chromosome 22","volume":"19","author":"Apte","year":"1994","journal-title":"Genomics"},{"key":"B92","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(18)41928-X","article-title":"A new inhibitor of metalloproteinases from chicken: chimp-3. A third member of the timp family","volume":"267","author":"Pavloff","year":"1992","journal-title":"J Biol Chem"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206292","article-title":"Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors","volume":"22","author":"Ahonen","year":"2003","journal-title":"Oncogene"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.ydbio.2006.07.004","article-title":"Tissue inhibitor of metalloproteinases 3 regulates extracellular matri X\u2013cell signaling during bronchiole branching morphogenesis","volume":"298","author":"Gill","year":"2006","journal-title":"Dev Biol"},{"key":"B95","first-page":"798","article-title":"Methylation-associated silencing of the tissue inhibitor of metallopro teinase-3 gene suggest a suppressor role in kidney, brain, and other H uman cancers","volume":"59","author":"Bachman","year":"1999","journal-title":"Cancer Res"},{"key":"B96","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1046\/j.1365-2141.1998.00754.x","article-title":"Human myeloma cells shed the interleukin-6 receptor: inhibition by tis sue inhibitor of metalloproteinase-3 and a hydroxamate-based metallopr oteinase inhibitor","volume":"101","author":"Hargreaves","year":"1998","journal-title":"Br J haematol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.48.30375","article-title":"Molecular cloning and characterization of human tissue inhibitor of me talloproteinase 4","volume":"271","author":"Greene","year":"1996","journal-title":"J Biol Chem"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704936","article-title":"Identification, regulation and role of tissue inhibitor of metalloprot einases-4 (Timp-4) in human platelets","volume":"137","author":"Radomski","year":"2002","journal-title":"Br J Pharmacol"},{"key":"B99","article-title":"Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase a via efficient inhibition of membrane T ype 1-matrix metalloproteinase","volume":"61","author":"Bigg","year":"2001","journal-title":"Cancer Res"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.impact.2021.100293","article-title":"Matrix metalloproteinase inhibitors (Mmpis) as attractive therapeutic targets: recent progress and current challenges","volume":"21","author":"Shi","year":"2021","journal-title":"NanoImpact"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1166\/jbt.2017.1555","article-title":"Effect of particle size of gold nanoparticles on matrix metalloprotease inhibition, cytotoxicity and genotoxicity","volume":"7","author":"Hashimoto","year":"2017","journal-title":"J Biomat Tissue Eng"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1127407\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T08:53:31Z","timestamp":1695804811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1127407\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,26]]},"references-count":101,"alternative-id":["10.3389\/fonc.2023.1127407"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1127407","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,26]]},"article-number":"1127407"}}